Work

De Odyssee Van Lisr: Een Reis Naar De Ribosomen Om Immuniteit Te Verslaan

Year: 2024
Type: dissertation
Abstract: Cancer cells are characterized by the capacity to divide relentlessly. To grow and divide, cancer and normal cells need to reach a critical mass, a goal that is achieved through the process of protein synthesis. Therefore it is not surprising that changes in protein synthesis occur in the cell during malignant transformation, many of which are causative of cancer. For this reason, many efforts have been made in the clinic to develop drugs that target this process for cancer treatment. Unfortunately, such an approach is not cancer specific and harms also normal cells, a problem that is the leading cause of therapeutic toxicity. Lately it was shown that the portion of the genome that was thought to not contain any functional gene, the so called "Junk DNA", produces instead a large number of molecules, called Long noncoding RNAs (lncRNA). A substantial portion of lncRNAs is associated with the protein synthesis machinery and could have regulatory roles. Moreover, they are often selectively expressed by specific cells and/or cancer cell populations. The aim of the project is to identify lncRNAs that regulate protein synthesis specifically in cancer cells and to use them as therapeutic targets. This would allow us to target protein synthesis in a cancer specific way leaving normal cells unharmed and therefore reducing the toxicity for the patients.
Source: Lirias
Institution: KU Leuven
Language: English
Subfield: Cancer Research
Open Access status: green
OpenAlex ID: W7008933370
Cites: 243
Cited by:
Related to: 10